Mark Senak, a US expert on pharmaceutical-related communications issues, has compiled on his Eye on FDA blog (www.eye_on_fda.com) a round-up of legislation in the US Congress that concerns the Food and Drug Administration. In the House of Representatives, Ron Paul (Republican, Texas) has proposed the Prescription Drug Affordability Act (HR 163), which would amend the federal tax code to allow retired citizens to make larger tax deductions for prescription drug expenses, as well as make imports legal. Rep Paul is the most averse to public spending national politician in the USA, so his focus is likely to be the reduction of income tax and Medicare spending.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
| Headless Content Management with Blaze